Arab News Japan

TOKYO: Tokyo-based Medident took advantage of the Japan-Saudi EXPO Investment Forum to seal a memorandum of understanding that will link Japan’s medical digital transformation strategy with Saudi Arabia’s Vision 2030, the company announced on Sept. 24. 

The agreement covers areas such as AI diagnostics, XR-based surgical training, medical device development, and healthcare-education platforms. Medident also plans to speed up clinical and educational adoption of its “3D Clone Model,” a training tool that combines VR with tactile simulation based on CT, MRI and intraoral scans.

“Our initiatives are gaining recognition both academically and at the policy level,” Medident CEO TOMITA Daisuke said. “By connecting Japan’s strengths in digital healthcare with Saudi Arabia’s reform agenda, we will build new frameworks for international co-creation.”

The deal was signed on stage at the Saudi-Japan EXPO Investment Forum with Dr. Noor A. Al-Saadoon, director of health innovation at the Biotech Center at Al-Faisal University; His Excellency Dr. Mohammed Al-Hayaza, President of Al-Faisal University; His Excellency Minister Khalid A. Al-Falih Ministry of Investment of the Kingdom of Saudi Arabia; KOGA Yuichiro, State Minister of Economy, Trade, and Industry; Medident CEO Daisuke Tomita; and Yumiko Tomita, Director of the Japan Oral Health Association.

Medident is part of the Mirise Medical Group, which operates clinics in Tokyo’s upmarket Minami-Aoyama and Ginza districts, focusing on orthodontics, oral health, and regenerative therapies.